These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35989210)

  • 1. Impact of mobile phone intervention on intermittent preventive treatment of malaria during pregnancy in Burkina Faso : A pragmatic randomized trial.
    Ouédraogo S; Accrombessi M; Ouattara A; Massougbodji A; Dabira ED; Sarigda M; Diallo I; Zida A; Nicolas M; Ouédraogo L; Cot M; Sondo B
    Rev Epidemiol Sante Publique; 2022 Oct; 70(5):209-214. PubMed ID: 35989210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial.
    COSMIC Consortium
    Clin Infect Dis; 2019 Feb; 68(4):586-596. PubMed ID: 29961848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
    Gies S; Coulibaly SO; Ouattara FT; Ky C; Brabin BJ; D'Alessandro U
    Malar J; 2008 Sep; 7():180. PubMed ID: 18801158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cluster randomized trial of delivery of intermittent preventive treatment of malaria in pregnancy at the community level in Burkina Faso.
    Gutman JR; Stephens DK; Tiendrebeogo J; Badolo O; Dodo M; Burke D; Williamson J; Vibbert K; Youll SJ; Savadogo Y; Brieger WR
    Malar J; 2020 Aug; 19(1):282. PubMed ID: 32758233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
    Azizi SC
    BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
    Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
    Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
    Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso.
    Natama HM; Toussaint R; Bazié DLC; Samadoulougou S; Coulibaly-Traoré M; Tinto H; Kirakoya-Samadoulougou F
    Malar J; 2020 Nov; 19(1):399. PubMed ID: 33172485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study.
    Coulibaly SO; Kayentao K; Taylor S; Guirou EA; Khairallah C; Guindo N; Djimde M; Bationo R; Soulama A; Dabira E; Barry B; Niangaly M; Diakite H; Konate S; Keita M; Traore B; Meshnick SR; Magnussen P; Doumbo OK; ter Kuile FO
    Malar J; 2014 Jan; 13():41. PubMed ID: 24484467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of group versus individual antenatal care on uptake of intermittent prophylactic treatment of malaria in pregnancy and related malaria outcomes in Nigeria and Kenya: analysis of data from a pragmatic cluster randomized trial.
    Noguchi L; Grenier L; Kabue M; Ugwa E; Oyetunji J; Suhowatsky S; Onguti B; Orji B; Whiting-Collins L; Adetiloye O
    Malar J; 2020 Jan; 19(1):51. PubMed ID: 31996209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of the uptake of intermittent preventive treatment of malaria in pregnancy with sulphadoxine pyrimethamine in Sabatia Sub County, Western Kenya.
    Mutanyi JA; Onguru DO; Ogolla SO; Adipo LB
    Infect Dis Poverty; 2021 Aug; 10(1):106. PubMed ID: 34362443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context.
    Aberese-Ako M; Magnussen P; Ampofo GD; Gyapong M; Ansah E; Tagbor H
    PLoS One; 2021; 16(10):e0257666. PubMed ID: 34618812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Kombila M
    BMC Pregnancy Childbirth; 2013 Feb; 13():52. PubMed ID: 23442536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso.
    Ruizendaal E; Tahita MC; Geskus RB; Versteeg I; Scott S; d'Alessandro U; Lompo P; Derra K; Traore-Coulibaly M; de Jong MD; Schallig HDFH; Tinto H; Mens PF
    Malar J; 2017 Apr; 16(1):179. PubMed ID: 28454537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso.
    Gies S; Coulibaly SO; Ky C; Ouattara FT; Brabin BJ; D'Alessandro U
    Am J Trop Med Hyg; 2009 Mar; 80(3):460-9. PubMed ID: 19270299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective evaluation of referral by community health workers on the uptake of intermittent preventive treatment of Malaria in pregnancy in Ohaukwu, Ebonyi State, Nigeria.
    Orji BC; Bryce E; Odio B; Onuoha HE; Njoku E; Anoke C; Ugwa E; Enne J; Oniyire A; Otolorin E; Afolabi K; Ogbulafor NC; Oliveras E
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):599. PubMed ID: 35896992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016.
    Okethwangu D; Opigo J; Atugonza S; Kizza CT; Nabatanzi M; Biribawa C; Kyabayinze D; Ario AR
    Malar J; 2019 Jul; 18(1):250. PubMed ID: 31349829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast.
    Yaya S; Kota K; Buh A; Bishwajit G
    BMC Public Health; 2019 Nov; 19(1):1467. PubMed ID: 31694607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent preventive treatment of malaria in pregnancy (IPTp): do frequent antenatal care visits ensure access and compliance to IPTp in Ugandan rural communities?
    Ndyomugyenyi R; Katamanywa J
    Trans R Soc Trop Med Hyg; 2010 Aug; 104(8):536-40. PubMed ID: 20227739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.